表紙
市場調查報告書

自動注射器全球市場 (2028年前)

Autoinjectors to 2028

出版商 Greystone Research Associates 商品編碼 926278
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
自動注射器全球市場 (2028年前) Autoinjectors to 2028
出版日期: 2020年02月24日內容資訊: 英文
簡介

本報告研究全球自動注射器市場,彙整產品概要、應用、市場基本結構、主要推動和阻礙因素、未來市場規模趨勢展望 (2028年前),分析在設計、材料選定、技術選擇時需留意的部分、主要市場參與企業及其主力產品、企業合作關係之建構情況、無線通信技術的導入與活用情況、左右未來市場的趨勢 (經濟性、技術、規範等)、相關市場趨勢展望 (預充填式注射器等)等情報。

目錄

  • 摘要整理
  • 市場機會
  • 藥劑傳輸市場動態
  • 注射劑經濟性
  • 市場成長推動因素
  • 預充填式注射器的激增
  • 邁向自我投藥方式
  • 人口結構變化
  • 一次性設計的創新
  • 生物醫藥品的快速增加
  • 治療用單株抗體
  • 推動治療藥需求的因素
  • 競爭環境
  • 風險因素
  • 自動注射器 - 實用化裝置
  • 手動式自動注射器
  • 自動式自動注射器 (自動注入裝置)
  • 一次性自動注射器
  • 自動注射器:產品概要
    • Molly (SHL Medical)
    • Molly RNS (SHLMedical)
    • Bertha (SHL Medical)
    • Maggie (SHL Medical)
    • Amber (SHL Medical)
    • SafeLock (SHL Medical)
    • VSDI +NIT (SHL Medical)
    • SDI MIX +NIT (SHL Medical)
    • Syrina S (Consort Medical)
    • Syrina AS (Consort Medical)
    • AutoJect 2 (Owen Mumford)
    • SelfDose (West Pharmaceutical Services)
    • DAI (SHL)
    • DAI 2 (SHL Medical)
    • Flexi-Q PFS (Elcam Medical)
    • OTS Autoinjector (Consort Medical)
    • Physioject (Becton Dickinson)
    • YpsoMate/YpsoMate 2.25 (Ypsomed)
    • Pro-Ject (Aptar)
    • Consort Medical ASI
    • Ypsomed VarioJect
    • Rotaject Technology (SHL Medical)
    • Viscala Autoinjector (Consort Medical)
    • Flexi-Q HV (Elcam Medical)
    • Intevia (Becton Dickinson)
    • Antares Pharma Autoinjectors
    • Dali Medical Devices
  • 開發階段的自動注射器
    • 支援無線通信的自動注射器
    • 特定產品用自動注射器
    • Alsuma/Sumatriptan Autoinjector
    • Sumatriptan (Dr. Reddy's)
    • Betaject 3/Interferon
    • Rebif/Rebidose (Merck Serono)
    • Bydureon BCise (AstraZeneca)
    • SmartJect (PA Consulting/Centocor)
    • Aimovig (Amgen/Novartis)
    • Enbrel SureClick (Amgen)
    • Makena (AMAG Pharmaceuticals)
    • Pegasys Proclick (Genentech/Roche)
    • Rasuvo (Medac Pharma)
    • Otrexup (Antares Pharma)
    • Evzio (Kaleo)
  • 自動注射器設計要素
    • 材料選擇問題
    • 零件數和設備成本
  • 安全性問題
    • 注射針插入深度
    • 投藥量檢測/注射確認
    • 冷凍乾燥藥劑/回溶
    • 人類工程/人體工學
    • 新興技術
    • 無線數據通信
  • 自動注射器 - 主要治療領域分析
    • 過敏/對策
    • 自體免疫疾病
    • 類風濕性關節炎
    • 乾癬
    • 多發性硬化症
    • 急診醫療
    • 肝炎
    • 造血劑
    • 荷爾蒙
    • 生殖健康
  • 市場因素
    • 醫療經濟學
  • 企業簡介
目錄
Product Code: ATJ746F

The number of drugs available in prefilled syringes as a percentage of all injectable drugs continues to grow. So too does the number of injectable drugs indicated for chronic conditions and self-administration. But suppliers of autoinjectors face several challenges as the market evolves and matures. Continued interest in plastic prefilled syringes will require non-brand specific injector manufacturers to validate that their devices function consistently and safely over the range of these emerging PFS devices - devices with rigidity, barrel lubricity and flexural properties that differ not insignificantly from type 1 glass. They will have to compete - in some cases head-on - with prefilled syringe suppliers, who are increasingly incorporating autoinjector-like ease-of-use features into their PFS designs to differentiate their product lines and in some cases to meet their pharma customer requirements for product-specific syringe designs.

What You Will Learn:

  • What autoinjectors can be paired with prefilled syringes for injectable drug delivery; what are the key market segments, market dynamics and market demographics?
  • What are the therapeutic demand drivers and commercial devices in key product segments?
  • What are the design factors, material selection issues, technologies and market development issues?
  • How big is the market? How is it growing? What will it look like in 2028?
  • Who are the leading injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?
  • What is the importance of pharma-device alliances and design partnerships on autoinjector commercialization and market access?
  • What is the impact of wirelessly connected autoinjectors on patient care and market growth?
  • What are the significant economic, technology, and regulatory factors affecting the market for autoinjectors?

Table of Contents

  • Executive Summary
  • The Market Opportunity
  • Delivery Market Dynamics
  • The Economics of Injectable Drugs
  • What's Driving the Growth?
  • Prefilled Syringes Proliferating
  • The Trend toward Self-Administration
  • Shifting Demographics
  • Innovation in Disposable Designs
  • Proliferation of Biological Drugs
  • Therapeutic Monoclonal Antibodies
  • Therapeutic Demand Drivers
  • Competitive Landscape
  • Risk Factors
  • Autoinjectors - Commercial Devices
  • Manual Injection Autoinjectors
  • Automated Injection Autoinjectors
  • Disposable Autoinjectors
  • Autoinjector Product Summaries
  • Molly (SHL Medical)
  • Molly RNS (SHLMedical)
  • Bertha (SHL Medical)
  • Maggie (SHL Medical)
  • Amber (SHL Medical)
  • SafeLock (SHL Medical)
  • VSDI +NIT (SHL Medical)
  • SDI MIX +NIT (SHL Medical)
  • Syrina S (Consort Medical)
  • Syrina AS (Consort Medical)
  • AutoJect 2 (Owen Mumford)
  • SelfDose (West Pharmaceutical Services)
  • DAI (SHL)
  • DAI 2 (SHL Medical)
  • Flexi-Q PFS (Elcam Medical)
  • OTS Autoinjector (Consort Medical)
  • Physioject (Becton Dickinson)
  • YpsoMate/YpsoMate 2.25 (Ypsomed)
  • Pro-Ject (Aptar)
  • Consort Medical ASI
  • Ypsomed VarioJect
  • Rotaject Technology (SHL Medical)
  • Viscala Autoinjector (Consort Medical)
  • Flexi-Q HV (Elcam Medical)
  • Intevia (Becton Dickinson)
  • Antares Pharma Autoinjectors
  • Dali Medical Devices
  • Development-stage Autoinjectors
  • Wirelessly Enabled Autoinjectors
  • Selected Product Specific Autoinjectors
  • Alsuma/Sumatriptan Autoinjector
  • Sumatriptan (Dr. Reddy's)
  • Betaject 3/Interferon
  • Rebif/Rebidose (Merck Serono)
  • Bydureon BCise (AstraZeneca)
  • SmartJect (PA Consulting/Centocor)
  • Aimovig (Amgen/Novartis)
  • Enbrel SureClick (Amgen)
  • Makena (AMAG Pharmaceuticals)
  • Pegasys Proclick (Genentech/Roche)
  • Rasuvo (Medac Pharma)
  • Otrexup (Antares Pharma)
  • Evzio (Kaleo)
  • Autoinjector Device Design Factors
  • Material Selection Issues
  • Part Counts and Device Cost
  • Safety Features
  • Needle Insertion Depth
  • Dose Inspection/Injection Confirmation
  • Lyophilized Drugs/Reconstitution
  • Human Engineering/Ergonomics
  • Emerging Technology
  • Wireless Data
  • Autoinjector - Key Therapeutic Sector Analysis
  • Anaphylaxis/Countermeasures
  • Autoimmune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis
  • Emergency Medicine
  • Hepatitis
  • Hematopoietics
  • Hormones
  • Reproductive Health
  • Market Factors
  • Healthcare Economics
  • Company Profiles